NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Alzamend Neuro, Inc. Common Stock Share Price Chart

O H L

Alzamend Neuro, Inc. Common Stock Performance Overview

Days Range
$1.83Low
$1.84High

Markets Today

Previous Close$1.84
Open$1.84
Volume42,653
Day's Range$1.83 - $1.84
52W Range$0.84 - $2.68
Market Cap$8.83 M

Historical Performance

1M Returns+21.05
3M Returns+50.82
6M Returns-4.17
1Y Returns-26.10
5Y Returns-99.95
10Y ReturnsNA

Alzamend Neuro, Inc. Common Stock Fundamentals

Market Cap$8.83 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-3.73
EPS TTM$-2.27
Quarterly Earnings Growth YOYN/A
PB Ratio10.62
EBITDA$-8.66 M
Profit MarginN/A
Market Cap$8.83 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-3.73
EPS TTM$-2.27
Quarterly Earnings Growth YOYN/A
PB Ratio10.62
EBITDA$-8.66 M
Profit MarginN/A

Alzamend Neuro, Inc. Common Stock Profit & Loss

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$1.14 M-$2.70 M-$998.11 K-$2.20 M-$2.87 M-$3.03 M
EBITDA -$1.13 M-$2.67 M-$970.42 K-$2.17 M-$2.84 M-$3.00 M
Interest Expense -$509-$2.48 K-$2.65 K-$1.34 K-$150-$2.00 K
Depreciation $12.69 K$27.68 K$27.68 K$27.68 K$27.68 K$27.68 K
Income Before Tax -$1.14 M-$2.70 M-$1.00 M-$2.20 M-$2.87 M-$3.03 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$1.14 M-$2.70 M-$1.00 M-$2.20 M-$2.87 M-$3.03 M
Net Profit Margin ------

Alzamend Neuro, Inc. Common Stock Financials Balance Sheet In USD

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Share Capital $78$314$380$380$425$482
Reserve & Surplus -$58.54 M-$61.24 M-$62.24 M-$64.44 M-$67.31 M-$70.33 M
Non-Current Liabilities $0$0$0$0$0$0
Current Liabilities $634.76 K$983.31 K$717.49 K$1.86 M$1.35 M$2.74 M
Total Liabilities $634.76 K$983.31 K$717.49 K$1.86 M$1.35 M$2.74 M
Fixed Assets $425.61 K$397.92 K$370.24 K$342.55 K$314.87 K$287.18 K
Current Assets $4.18 M$5.93 M$4.72 M$3.70 M$1.76 M$8.25 M
Total Assets $4.60 M$6.33 M$5.09 M$4.04 M$2.08 M$8.54 M

Alzamend Neuro, Inc. Common Stock Cash Flow

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Net Income -$1.14 M-$2.70 M-$1.00 M-$2.20 M-$2.87 M-$3.03 M
Operating Cash Flow -$688.71 K-$2.36 M-$1.17 M-$1.74 M-$2.80 M-$1.14 M
Investing Cash Flow -$210.00 K$0$0$0$0$0
Financing Cash Flow $1.49 M$4.04 M$0$0$794.84 K$8.02 M
Change in Cash $590.52 K$1.67 M-$1.17 M-$1.74 M-$2.00 M$6.88 M

Alzamend Neuro, Inc. Common Stock Return Calculator

The Alzamend Neuro, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5
Invested Amount$10,000
Est. Returns$-9,995
Invest in USA Stock Today

About Alzamend Neuro, Inc. Common Stock

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

FAQs

Alzamend Neuro, Inc. Common Stock (ALZN) share price as of September 18, 2026 is $1.80. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Alzamend Neuro, Inc. Common Stock (ALZN) Share by opening an international trading account with Angel One.
Purchasing Alzamend Neuro, Inc. Common Stock (ALZN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Alzamend Neuro, Inc. Common Stock (ALZN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Alzamend Neuro, Inc. Common Stock (ALZN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Alzamend Neuro, Inc. Common Stock on September 18, 2026, is $8.83 M.
Alzamend Neuro, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Alzamend Neuro, Inc. Common Stock (ALZN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91